semaglutide helps with addiction GLP-1 weight-loss drugs may also curb alcohol cravings GLP-1s and Addiction: What the

Incretin hormones in obesity and related cardiometabolic disorders: the clinical perspective

has received honoraria from Astra Zeneca, Eli Lilly, Novartis, Novo Nordisk and Sanofi

Mutually stimulating interactions between lactic acid bacteria and Saccharomyces cerevisiae in sourdough fermentation

Next-Generation Oral GLP-1 Medicines Research is now focused on developing new oral GLP-1 medicines that aim to: Remove the need for injections Improve convenience Reduce common side effects like nausea As outlined in the Zydus project document, novel oral GLP-1 candidates are being developed to make long-term treatment easier and more patient-friendly, especially for people hesitant about injections

This makes sure that the right people handle the powder at all times in the supply chain